| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Thomas Skovlund Schnegelsberg CEO | XCSE Exchange | DK0061078425 ISIN |
| DK Country | 8 Employees | - Last Dividend | 22 May 2023 Last Split | - IPO Date |
Stenocare A/S is a pioneering enterprise in the medical cannabis industry, focusing on the cultivation, production, importation, sale, and distribution of prescription-based medical cannabis products. Established in 2017, the company operates out of Randers, Denmark, catering to the medical needs of patients across Danish and European markets. Stenocare’s business model emphasizes providing high-quality medical cannabis products under stringent regulatory compliance, ensuring patient safety and product efficacy.
Stenocare A/S has specialized in a range of medical cannabis oil products, designed to meet the therapeutic needs of patients with various medical conditions. The company's product line includes: